Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Gschwantler, M ; Asselah, T ; Moreno, C ; Sarrazin, C ; Foster, GR ; Craxi, A ; Buggisch, P ; Ryan, R ; Lenz, O ; Van Dooren, G ; Lonjon-Domanec, I ; Schlag, M ; Buti, M

Zeitschrift für Gastroenterologie, 2015-05, Vol.53 (5) [Periódico revisado por pares]

Texto completo disponível